<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38297181</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1348-4214</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Hypertension research : official journal of the Japanese Society of Hypertension</Title><ISOAbbreviation>Hypertens Res</ISOAbbreviation></Journal><ArticleTitle>The necessity of investigations to clarify sex and racial disparities in pathophysiology of Long COVID.</ArticleTitle><Pagination><StartPage>984</StartPage><EndPage>986</EndPage><MedlinePgn>984-986</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41440-024-01587-w</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Chisa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Health Surveillance &amp; Preventive Medicine, Tokyo Medical University Hospital, Tokyo, Japan. Chisa-ma@tokyo-med.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Tokyo Medical University Hospital, Tokyo, Japan. Chisa-ma@tokyo-med.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hypertens Res</MedlineTA><NlmUniqueID>9307690</NlmUniqueID><ISSNLinking>0916-9636</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002121">Calcium Channel Blockers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Hypertens Res. 2024 Apr;47(4):934-943. doi: 10.1038/s41440-023-01501-w</RefSource><PMID Version="1">37978232</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002121" MajorTopicYN="Y">Calcium Channel Blockers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Calcium channel blocker</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Racial difference</Keyword><Keyword MajorTopicYN="N">Sex difference</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>31</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38297181</ArticleId><ArticleId IdType="doi">10.1038/s41440-024-01587-w</ArticleId><ArticleId IdType="pii">10.1038/s41440-024-01587-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins University (JHU). Corona Virus Resource Center. COVID-19 Dashboard. 2023 https://coronavirus.jhu.edu/map.html .</Citation></Reference><Reference><Citation>Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, et al. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. Jama. 2022;328:1604&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId><ArticleId IdType="pmc">9552043</ArticleId></ArticleIdList></Reference><Reference><Citation>Tufts J, Guan N, Zemedikun DT, Subramanian A, Gokhale K, Myles P, et al. The cost of primary care consultations associated with long COVID in non-hospitalised adults: a retrospective cohort study using UK primary care data. BMC Prim Care. 2023;24:245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12875-023-02196-1</ArticleId><ArticleId IdType="pubmed">37986044</ArticleId><ArticleId IdType="pmc">10662438</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto C, Shibata S, Kishi T, Morimoto S, Mogi M, Yamamoto K, et al. Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19. Hypertens Res. 2023;46:601&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-01145-2</ArticleId><ArticleId IdType="pubmed">36575228</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G, Diodati F, Puntoni M, Lazzarelli S, Marcomini B, Patrizi L, et al. Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. J Clin Med. 2022;11:1541.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId><ArticleId IdType="pmc">8948827</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozawa T, Kimura R, Terai H, Takemura R, Namkoong H, Kondo M, et al. Calcium channel blockers may reduce the development of long COVID in females. Hypertens Res. 2023. https://doi.org/10.1038/s41440-023-01501-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-023-01501-w</ArticleId><ArticleId IdType="pubmed">37978232</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojciechowska W, Terlecki M, Klocek M, Pac A, Olszanecka A, Stolarz-Skrzypek K, et al. Impact of Arterial Hypertension and Use of Antihypertensive Pharmacotherapy on Mortality in Patients Hospitalized due to COVID-19: The CRACoV-HHS Study. Hypertension. 2022;79:2601&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.122.19575</ArticleId><ArticleId IdType="pubmed">36082666</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow CS, Ramachandram DS, Hasan SS. Use of Calcium Channel Blockers and the Risk of All-cause Mortality and Severe Illness in Patients With COVID-19: A Systematic Review and Meta-analysis. J Cardiovasc Pharm. 2022;79:199&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000001144</ArticleId></ArticleIdList></Reference><Reference><Citation>Fani M, Moossavi M, Bakhshi H, Jahrodi AN, Khazdair MR, Zardast AH, et al. Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy. Future Virol. 2023;18:797&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl-2022-0203</ArticleId></ArticleIdList></Reference><Reference><Citation>Crespi B, Alcock J. Conflicts over calcium and the treatment of COVID-19. Evol Med Public Health. 2021;9:149&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emph/eoaa046</ArticleId><ArticleId IdType="pubmed">33732462</ArticleId></ArticleIdList></Reference><Reference><Citation>Khullar D, Zhang Y, Zang C, Xu Z, Wang F, Weiner MG, et al. Racial/Ethnic Disparities in Post-acute Sequelae of SARS-CoV-2 Infection in New York: an EHR-Based Cohort Study from the RECOVER Program. J Gen Intern Med. 2023;38:1127&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07997-1</ArticleId><ArticleId IdType="pubmed">36795327</ArticleId><ArticleId IdType="pmc">9933823</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>